What is the latest price of bosutinib/bosutinib in 2025
Bosutinib/Bosutinib is an oral kinase inhibitor used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) in newly diagnosed adults and in patients who have no longer responded to other chronic myelogenous drugs or are unable to use these drugs due to side effects. It helps prevent the spread of cancer cells by blocking the activity of an abnormal protein that inhibits cancer cells' reproduction signals.
Bosutinib is usually taken in tablet form once daily with food, and patients are advised to take it at the same time each day to ensure maximum effectiveness. When taking it, you must strictly follow the doctor's instructions and do not increase or decrease the dosage at will. The tablets must be swallowed whole and do not cut, chew or crush. If the tablet is broken or crushed, do not touch it directly with your hands. The doctor will adjust the dose or decide whether to stop treatment in a timely manner based on the patient's response to treatment and possible side effects. Even if patients feel well, they still need to insist on taking bosutinib on time to ensure the continued effect of the treatment.
The originator drug of bosutinib has not yet been launched in China, so its domestic price is unclear. The original research versions currently sold overseas include the Swiss version, the Turkish version, and the European version. The Turkish version's specifications500mg*28 tablets may be sold for more than 2,000 yuan per box; while the European and Swiss versions may be sold for around 40,000 yuan per box (prices may fluctuate due to exchange rates).
At the same time, there are also bosutinib generic drugs produced overseas in other countries, and their pharmaceutical ingredients are basically the same as those of the original drug. For example, the specifications of 100mg*120 tablets produced by Indian pharmaceutical factories may be priced at more than 1,000 yuan per box (the price may fluctuate due to exchange rates), and the price is relatively cheap.
Reference materials:https://medlineplus.gov/druginfo/meds/a613005.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)